Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

BA-BE Studies: SOP for Environmental Monitoring in Volunteer Areas – V 2.0

Posted on By

BA-BE Studies: SOP for Environmental Monitoring in Volunteer Areas – V 2.0

Standard Operating Procedure for Environmental Monitoring in Volunteer Areas during BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/117/2025
Supersedes SOP/BA-BE/117/2022
Page No. Page 1 of 9
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To define the procedure for systematic environmental monitoring in volunteer housing, dosing, and recreation areas during the conduct of BA/BE studies to ensure hygienic, safe, and comfortable conditions for study subjects.

2. Scope

This SOP applies to clinical site personnel, housekeeping, and maintenance staff responsible for environmental conditions in areas designated for volunteer accommodation and movement in BA/BE study units.

3. Responsibilities

  • Facility Maintenance Officer: Monitors and records temperature, humidity, air changes, and lighting.
  • Housekeeping Supervisor: Ensures cleanliness and sanitation as per the defined schedule.
  • Clinical Research Coordinator: Ensures volunteer areas are prepared before admission and reports environmental deviations.
  • QA Officer: Audits environmental logs and investigates deviations from acceptable limits.
See also  BA-BE Studies: SOP for Monitoring Compliance of Subject Activities - V 2.0

4. Accountability

The Clinical Facility Manager is accountable for maintaining compliant environmental conditions across volunteer areas as per GCP and regulatory guidelines.

5. Procedure

5.1 Environmental Parameters and Frequency

  1. Monitor and document:
    • Room temperature (acceptable: 22°C to 26°C)
    • Relative humidity (acceptable: 40% to 60%)
    • Air changes per hour (minimum 6 ACH)
    • Lighting (minimum 300 lux)
  2. Use Annexure-1: Environmental Monitoring Log to record values twice per day (morning and evening).

5.2 Equipment and Calibration

  1. Use calibrated digital thermohygrometers, lux meters, and airflow anemometers.
  2. Calibrate each device quarterly and maintain certificates in Annexure-2: Equipment Calibration Register.

5.3 Cleanliness and Sanitation

  1. Ensure daily sweeping, mopping, and surface sanitization of volunteer areas.
  2. Document activities in Annexure-3: Cleaning and Disinfection Log.
  3. Ensure availability of clean bedsheets, toiletries, dustbins, and disinfectants.

5.4 Pest Control

  1. Conduct pest control monthly using agency-approved non-toxic fumigants.
  2. Document schedule and service records in Annexure-4: Pest Control Log.
See also  BA-BE Studies: SOP for Managing Female Volunteers in BA/BE Trials - V 2.0

5.5 Deviation Handling

  1. If any parameter exceeds the defined range:
    • Inform Maintenance and QA immediately
    • Initiate Annexure-5: Environmental Deviation Report
    • Implement CAPA and restore normal conditions within 2 hours

5.6 Staff Training

  1. Train all facility and housekeeping staff quarterly on environmental hygiene SOP.
  2. Document training in Annexure-6: Training Record.

6. Abbreviations

  • BA: Bioavailability
  • BE: Bioequivalence
  • GCP: Good Clinical Practice
  • QA: Quality Assurance
  • ACH: Air Changes per Hour
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Environmental Monitoring Log – Annexure-1
  2. Equipment Calibration Register – Annexure-2
  3. Cleaning and Disinfection Log – Annexure-3
  4. Pest Control Log – Annexure-4
  5. Environmental Deviation Report – Annexure-5
  6. Training Record – Annexure-6

8. References

  • ICH E6(R2) – Good Clinical Practice
  • WHO Guidelines for Volunteer Accommodation
  • Schedule Y – Drugs and Cosmetics Rules

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department
See also  BA-BE Studies: SOP for IEC/IRB Continuing Review Applications - V 2.0

11. Annexures

Annexure-1: Environmental Monitoring Log

Date Time Room Temp (°C) RH (%) ACH Lighting (Lux) Checked By
17/04/2025 08:00 AM 24.2 52 6.5 310 Rajesh Kumar

Annexure-2: Equipment Calibration Register

Device Model No. Calibration Date Next Due Calibrated By
Thermohygrometer THG-600 01/04/2025 01/07/2025 Sunita Reddy

Annexure-3: Cleaning and Disinfection Log

Date Area Cleaning Time Supervisor Remarks
17/04/2025 Volunteer Dorm A 07:00 AM Ajay Verma Complete

Annexure-4: Pest Control Log

Date Service Agency Area Covered Method Remarks
01/04/2025 PestSecure India Dorms, Dining Fumigation OK

Annexure-5: Environmental Deviation Report

Date Parameter Observed Value Acceptable Range CAPA
16/04/2025 Humidity 67% 40–60% AC serviced, dehumidifier used

Annexure-6: Training Record

Name Role Training Date Trainer Remarks
Meena Joshi Housekeeper 10/04/2025 QA Officer Trained

Revision History:

Revision Date Revision No. Details Reason Approved By
05/01/2022 1.0 Initial Release Regulatory Requirement QA Head
17/04/2025 2.0 Added monitoring frequency, ACH, lighting metrics, and deviation logs Internal Audit QA Head
BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

Post navigation

Previous Post: API Manufacturing: SOP for IPC Sample Retention Procedure – V 2.0
Next Post: Creams: SOP for Odor Stability Testing in Cream Formulations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version